About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
How I Manage Immune Adverse Events in Solid Tumors
By
Balazs Halmos
4 Videos
1,881 views
December 13, 2022
0 Comments
Login to view comments.
Click here to Login
Featured Video
19:22
Janssen Oncology
Doc Talk Podcast
Feat.
J. Hamilton,
M. Fabrizio,
M. Taha
Featured Video
21:09
Exelixis
Primary Analysis and Follow-up Data of a Combination Therapy in 1L a…
Feat.
S. Ratnam
Related Content
AUTOPLAY
ON
57:44
Vogl, NY
Vogl,NY on How to Ask Good Questions at Medical Meetings
Feat.
S. Vogl
08:49
David Carbone
The Use of IO Doublet in PD-L1-Negative NSCLC
35:40
Balazs Halmos
Year in Review: Lung Cancer
16:05
Insights from 2024 ASCO® GU Annual Meeting
Recent GU Developments and Their Clinical Implications
Feat.
T. Powles,
B. Rini
19:39
Vanderbilt University Medical Center (VUMC)
Helicobacter Pylori: A Bacterium That Causes Gastric Cancer
Feat.
R. Peek
17:20
Total Health
2024 Intervention Selection & Sequencing in Early Stage NSCLC
Feat.
J. Porter
10:22
Houston Methodist Hospital
mRNA Vaccine in Treatment of Pancreatic Cancer
Feat.
J. Gonzalez
27:04
Fengting Yan
Cancer Screening Molecular Tools
13:37
SIR 2023 Conference Coverage
SIR 2023: Renal Cell Carcinoma Guidelines - What's New in 2023?
Feat.
N. Kothary
25:35
Total Health
NGS and Liquid Biopsy: Overcoming Challenges in Widespread Testing
Feat.
S. Kazmi
15:58
Total Health
Best of Bladder Cancer and RCC From ESMO 2023 and GU ASCO 2024
Feat.
M. Reimers
27:12
Moffitt Cancer Center
Year in Review: Upper GI Cancers
Feat.
R. Kim,
R. Mehta
13:19
IASLC Targeted Therapies of Lung Cancer 2023 Conference Coverage
Duration of Immunotherapy Beyond 2 Years for Patients With Advanced …
Feat.
E. Rodriguez
25:18
Janakiraman Subramanian
Updates in Small Cell Lung Carcinoma
07:43
Yale Cancer Center
2024 Updates on NSCLC Targeted Therapies: FLAURA2 Trial - Osimertini…
Feat.
P. Janne
17:50
AdventHealth
Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…
Feat.
G. Sonpavde
14:49
Vivek Subbiah
Year in Review: Precision Medicine
18:35
2023 Evolution Conference
Recent Updates in SCLC
Feat.
S. Kazmi
30:27
Insights from 2023 ESMO Annual Meeting
Perioperative Immunotherapy Strategies in Resectable NSCLC After ESM…
Feat.
G. Mountzios
26:21
Memorial Sloan Kettering Cancer Center
NSCLC & Targeted Therapy: A Brief Overview and Update in the Met…
Feat.
M. Hwang